If you have any question, please feel free to email us. We will touch with you as soon as possible.
CAS:5817-39-0
Source:India
Qualifications:-/-/-/-/-
Name | Liothyronine |
---|---|
Chinese name | 碘塞罗宁 |
Cas Number | 5817-39-0 |
Source | India |
Qualifications | -/-/-/-/- |
The main component of liothyronine is synthetic sodium triiodothyronine, which has a similar effect to thyroxine, and its efficacy is 3-5 times that of thyroxine. From a theoretical point of view, the advantage of sodium triiodothyronine treatment is that it can avoid the conversion of thyroxine to sodium triiodothyronine in treatment of levothyroxine, which directly causes active triiodothyronine. Sodium orthosinate plays its role. For many patients, thyroxine alone is not enough because the body's ability to convert thyroxine into liothyronine (T3) is limited, which is more biologically active than thyroxine. Compared to thyroxine alone, a mixture of thyroid hormone and liothyronine may be a more effective form of treatment. The Tokyo Metropolitan Children's Medical Center found that liothyronine and propranolol can treat wasting hypothyroidism caused by hepatic hemangioma, which provides the application of triiodothyronine sodium in hypothyroidism New understanding.
Hot Tags: liothyronine api, China, suppliers, manufacturers, factory, customized, price, pricelist, in stock, Vinpocetine API, Fulvestrant API, Ticagrelor API, Deoxycholic Acid API, Oseltamivir Phosphate API, Tetrabenazine API
Tel:+86-020-61855200-902
Fax:+86-020-66392525
Email:info@upharm.cn
Address:12th floor, No. 181, Kexue Avenue, Huangpu District, Guangzhou, China